Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Venture Capital
Biotech
Syncona blames biotech bear market for ‘disappointing’ returns
Life sciences investor Syncona blamed a “disappointing” drop in returns on plummeting share prices for British biotechs across its portfolio.
James Waldron
Feb 7, 2023 10:31am
Fierce Biotech Fundraising Tracker: IgGenix, Ribon and more
Feb 7, 2023 9:36am
Investment in pain and addiction not matching burden: report
Feb 2, 2023 6:00am
Paradigm debuts with $203M series A funding
Jan 31, 2023 3:20pm
Despite blockbuster Altos funds, longevity investment falls $1B
Jan 31, 2023 11:28am
Structure finalizes $111M IPO; Intensity plots offering
Jan 30, 2023 10:59am
